Chicago Partners Investment Group’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.65M | Buy |
20,060
+11,094
| +124% | +$895K | 0.03% | 431 |
|
|
2026
Q1 | $746K | Sell |
8,966
-4,638
| -34% | -$444K | 0.02% | 666 |
|
|
2025
Q4 | $1.37M | Sell |
13,604
-181
| -1% | -$17.6K | 0.03% | 379 |
|
|
2025
Q3 | $1.29M | Buy |
13,785
+5,591
| +68% | +$514K | 0.03% | 366 |
|
|
2025
Q2 | $754K | Buy |
8,194
+1,224
| +18% | +$104K | 0.02% | 463 |
|
|
2025
Q1 | $580K | Sell |
6,970
-39
| -0.6% | -$3.49K | 0.02% | 479 |
|
|
2024
Q4 | $579K | Buy |
7,009
+2,139
| +44% | +$185K | 0.02% | 462 |
|
|
2024
Q3 | $449K | Buy |
4,870
+1,337
| +38% | +$112K | 0.02% | 518 |
|
|
2024
Q2 | $286K | Sell |
3,533
-53
| -1% | -$4.34K | 0.01% | 605 |
|
|
2024
Q1 | $292K | Buy |
3,586
+85
| +2% | +$7.25K | 0.01% | 578 |
|
|
2023
Q4 | $297K | Sell |
3,501
-352
| -9% | -$26.8K | 0.01% | 546 |
|
|
2023
Q3 | $279K | Sell |
3,853
-951
| -20% | -$79.6K | 0.02% | 528 |
|
|
2023
Q2 | $411K | Buy |
4,804
+1,218
| +34% | +$105K | 0.02% | 464 |
|
|
2023
Q1 | $322K | Buy |
3,586
+45
| +1% | +$3.67K | 0.02% | 493 |
|
|
2022
Q4 | $307K | Sell |
3,541
-53
| -1% | -$4.3K | 0.02% | 474 |
|
|
2022
Q3 | $307K | Buy |
3,594
+198
| +6% | +$17.8K | 0.02% | 428 |
|
|
2022
Q2 | $314K | Sell |
3,396
-143
| -4% | -$14.5K | 0.02% | 429 |
|
|
2022
Q1 | $367K | Buy |
3,539
+359
| +11% | +$37.9K | 0.03% | 380 |
|
|
2021
Q4 | $325K | Sell |
3,180
-222
| -7% | -$25.7K | 0.02% | 421 |
|
|
2021
Q3 | $407K | Buy |
3,402
+7
| +0.2% | +$906 | 0.03% | 371 |
|
|
2021
Q2 | $435K | Sell |
3,395
-143
| -4% | -$18K | 0.03% | 348 |
|
|
2021
Q1 | $460K | Buy |
3,538
+495
| +16% | +$58K | 0.04% | 314 |
|
|
2020
Q4 | $355K | Buy |
3,043
+541
| +22% | +$59.6K | 0.03% | 336 |
|
|
2020
Q3 | $258K | Sell |
2,502
-222
| -8% | -$22.3K | 0.03% | 342 |
|
|
2020
Q2 | $263K | Buy |
2,724
+378
| +16% | +$36.2K | 0.03% | 314 |
|
|
2020
Q1 | $242K | Buy |
2,346
+79
| +3% | +$8.4K | 0.04% | 293 |
|
|
2019
Q4 | $269K | Buy |
2,267
+132
| +6% | +$14.5K | 0.03% | 302 |
|
|
2019
Q3 | $225K | Buy |
+2,135
| New | +$223K | 0.03% | 302 |
|
|
2019
Q1 | – | Sell |
-2,699
| Closed | -$229K | – | 343 |
|
|
2018
Q4 | $229K | Hold |
2,699
| – | – | 0.03% | 286 |
|
|
2018
Q3 | $241K | Hold |
2,699
| – | – | 0.04% | 271 |
|
|
2018
Q2 | $231K | Buy |
2,699
+530
| +24% | +$44.3K | 0.04% | 253 |
|
|
2018
Q1 | $174K | Buy |
2,169
+368
| +20% | +$30.4K | 0.03% | 270 |
|
|
2017
Q4 | $145K | Buy |
1,801
+1,040
| +137% | +$83.3K | 0.02% | 303 |
|
|
2017
Q3 | $59K | Buy |
761
+415
| +120% | +$34.5K | 0.01% | 413 |
|
|
2017
Q2 | $27K | Sell |
346
-242
| -41% | -$20.4K | 0.01% | 476 |
|
|
2017
Q1 | $47K | Buy |
+588
| New | +$45.9K | 0.01% | 322 |
|
|
2015
Q2 | – | Sell |
-196
| Closed | -$14K | – | 475 |
|
|
2015
Q1 | $14K | Buy |
196
+15
| +8% | +$1.14K | 0.01% | 317 |
|
|
2014
Q4 | $13K | Buy |
+181
| New | +$12.6K | 0.01% | 337 |
|
Other funds holding MDT
Chicago Partners Investment Group's MDT Position: Q2 2026 in Review
Chicago Partners Investment Group increased its Medtronic (MDT) stake by 124% in Q2 2026, buying an estimated $895K and bringing the position to 20,060 shares worth $1.65M. The position accounts for 0.03% of the portfolio, ranked #431.
Chicago Partners Investment Group first reported a position in MDT in Q4 2014 and has held it in 38 quarters since. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Chicago Partners Investment Group held 20,060 shares of Medtronic worth $1.65M as of Q2 2026.
- Chicago Partners Investment Group bought 11,094 Medtronic shares in Q2 2026, an estimated $895K.
- Medtronic made up 0.03% of Chicago Partners Investment Group's portfolio in Q2 2026, its #431 holding.
- Chicago Partners Investment Group first reported a position in Medtronic in Q4 2014 and has held it in 38 quarters since.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.